X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$3.50
+1.76%
Mkt Cap $330.12M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
Implied Upside
+233.4%
Consensus $11.67 vs current $3.50
NASDAQ·Healthcare·Biotechnology
$3.50
+1.76%
Mkt Cap $330.12M
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
+233.4%
Consensus $11.67 vs current $3.50